Skip to main content

The Difficulties of Informed Consent in Stem Cell Transplant

Abstract

Informed consent is the process by which a competent patient is provided with a sufficient amount of relevant information to make an educated decision about a procedure. The process of informed consent is designed to prioritize patients’ autonomy. Stem cell transplant (SCT) is a complicated process with many possible results and requirements for on-going decision-making depending on outcomes and complications. While understanding basic theories of decision science will help the physician provide improved information at the time of consent, experiential learning by the patients as they proceed through SCT may have the strongest influence in continued patient decision-making that may or may not align with their initial informed consent.

This is a preview of subscription content, access via your institution.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Beecher HK. Ethics and clinical research. N Engl J Med. 1966;274:1354–60.

    CAS  Article  PubMed  Google Scholar 

  2. D’Souza A, Pasquini M, Spellecy R. Is ‘informed consent’ an ‘understood consent’ in hematopoietic cell transplantation? Bone Marrow Transplant. 2015;50:10–4. A comprehensive review of the key literature and research around informed consent for hematopoietic stem cell transplant.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Rosenbaum L. The paternalism preference—choosing unshared decision making. N Engl J Med. 2014;373:7.

    Google Scholar 

  4. Boland F. The first anesthetic: the story of Crawford Long. Athens: University Georgia Press; 2009.

  5. www.cancer.org. Accessed on 13 Oct 2015.

  6. Watson K. Reframing regret. JAMA. 2014;311(1):27–9. A descriptive piece defining decisional regret and situational regret.

    CAS  Article  PubMed  Google Scholar 

  7. Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912–9.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. Parimon T, Au DH, Martin PJ, et al. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med. 2006;144(6):407–14.

    Article  PubMed  Google Scholar 

  9. Servias S, Porcher R, Xhaard A, et al. Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors. Haematologica. 2014;99:519–26.

    Article  Google Scholar 

  10. Gratwohl A, Hermans J, Goldman JM, et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet. 1998;352:1087–92.

    CAS  Article  PubMed  Google Scholar 

  11. Peters E, Hibbard J, Slovic P, Dieckmann N. Numeracy skill and the communication, comprehension, and use of risk-benefit information. Health Aff (Project Hope). 2007;26:741–8.

    Article  Google Scholar 

  12. Lipkus IM, Samsa G, Rimer BK. General performance on a numeracy scale among highly educated samples. Med Decis Mak: Int J Soc Med Decis Mak. 2001;21:37–44.

    CAS  Article  Google Scholar 

  13. Lee SJ, Fairclough D, Antin JH, Weeks JC. Discrepancies between patient and physician estimates for the success of stem cell transplantation. JAMA. 2001;285:1034–8.

    CAS  Article  PubMed  Google Scholar 

  14. Grulke N, Bailer H. Facing haematopoietic stem-cell transplantation: do patients and their physicians agree regarding the prognosis? Psycho-Oncology. 2010;19:1035–43.

    Article  PubMed  Google Scholar 

  15. Schwarze ML, Redmann AJ, Alexander GC, et al. Surgeons expect patients to buy-in to postoperative life support preoperatively: results of a national survey. Crit Care Med. 2013;41(1):1–8.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Jacoby LH, Baloy B, Cirenza E, et al. The basis of informed consent for BMT patients. Bone Marrow Transplant. 1999;23:711–7.

    CAS  Article  PubMed  Google Scholar 

  17. Kahneman D. Thinking, fast and slow. New York: Farrar, Straus and Giroux; 2011.

    Google Scholar 

  18. Thaler, Sunstein. Nudge, improving decisions about health, wealth, and happiness. New Haven: Yale University Press; 2008. p. 293.

    Google Scholar 

  19. Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;47(2):263–91.

    Article  Google Scholar 

  20. McNeil BJ, Pauker SG, Sox Jr HC, Tversky A. On the elicitation of preferences for alternative therapies. N Engl J Med. 1982;306:1259–62.

    CAS  Article  PubMed  Google Scholar 

  21. National Research Council. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press; 2001.

    Google Scholar 

  22. Pidala J, Craig BM, Lee SJ, Majhail N, Quinn G, Anasetti C. Practice variation in physician referral for allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2013;48:63–7.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  23. Smith AR, Warlick ED, Roesler MA, et al. Factors associated with hematopoietic cell transplantation (HCT) among patients in a population-based study of myelodysplastic syndrome (MDS) in Minnesota. Ann Hematol. 2015;94:1667–75.

    CAS  Article  PubMed  Google Scholar 

  24. Forsyth R, Scanlan C, Carter SM, Jordens CF, Kerridge I. Decision making in a crowded room: the relational significance of social roles in decisions to proceed with allogeneic stem cell transplantation. Qual Health Res. 2011;21:1260–72.

    Article  PubMed  Google Scholar 

  25. Payne JW, Bettman JR. Behavioral decision research: a constructive processing perspective. Annu Rev Psychol. 1992;43:87–131.

    Article  Google Scholar 

  26. Halpern SD, Loewenstein G, Volpp K, et al. Default options in advance directives influence how patients set goals for end-of-life care. Health Aff. 2013;32(2):408–17. A randomized study of advance directives with different default options, given to seriously ill patients, demonstrated the absence of deeply-held beliefs when it was seen that the ‘pre-checked’ default option strongly influenced patients’ choices regarding end of life ‘aggressiveness’ of care.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Rachel J. Cook.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Stem Cell Transplantation

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cook, R.J., Runaas, L.N. The Difficulties of Informed Consent in Stem Cell Transplant. Curr Hematol Malig Rep 11, 1–5 (2016). https://doi.org/10.1007/s11899-016-0301-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11899-016-0301-x

Keywords

  • Informed consent
  • Autonomy
  • Stem cell transplant